| Disease | Target Count | P-value |
|---|---|---|
| lung carcinoma | 2843 | 4.3e-29 |
| juvenile dermatomyositis | 1187 | 1.6e-10 |
| Astrocytoma, Pilocytic | 3081 | 7.9e-08 |
| glioblastoma | 5792 | 3.9e-07 |
| adult high grade glioma | 3801 | 2.3e-06 |
| malignant mesothelioma | 3232 | 4.8e-06 |
| posterior fossa group A ependymoma | 468 | 7.1e-05 |
| ovarian cancer | 8520 | 9.3e-04 |
| subependymal giant cell astrocytoma | 2287 | 4.3e-03 |
| intraductal papillary-mucinous carcinoma (IPMC) | 2989 | 4.4e-03 |
| pituitary cancer | 1972 | 5.4e-03 |
| intraductal papillary-mucinous neoplasm (IPMN) | 3291 | 5.8e-03 |
| lung cancer | 4740 | 6.5e-03 |
| osteosarcoma | 7950 | 6.8e-03 |
| cutaneous lupus erythematosus | 1057 | 1.1e-02 |
| esophageal adenocarcinoma | 737 | 2.1e-02 |
| active ulcerative colitis | 764 | 2.2e-02 |
| pancreatic ductal adenocarcinoma liver metastasis | 1962 | 3.1e-02 |
| active Crohn's disease | 922 | 4.8e-02 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Primary biliary cirrhosis | 51 | 3.121 | 1.6 |
| Disease | log2 FC | p |
|---|---|---|
| active Crohn's disease | 1.056 | 4.8e-02 |
| active ulcerative colitis | 1.198 | 2.2e-02 |
| adult high grade glioma | 2.000 | 2.3e-06 |
| Astrocytoma, Pilocytic | 2.100 | 7.9e-08 |
| cutaneous lupus erythematosus | 1.600 | 1.1e-02 |
| esophageal adenocarcinoma | 1.200 | 2.1e-02 |
| glioblastoma | 1.800 | 3.9e-07 |
| intraductal papillary-mucinous carcinoma... | 1.100 | 4.4e-03 |
| intraductal papillary-mucinous neoplasm ... | 1.200 | 5.8e-03 |
| juvenile dermatomyositis | 1.033 | 1.6e-10 |
| lung cancer | -1.700 | 6.5e-03 |
| lung carcinoma | -2.100 | 4.3e-29 |
| malignant mesothelioma | 1.300 | 4.8e-06 |
| osteosarcoma | -2.041 | 6.8e-03 |
| ovarian cancer | 1.200 | 9.3e-04 |
| pancreatic ductal adenocarcinoma liver m... | 1.167 | 3.1e-02 |
| pituitary cancer | -1.200 | 5.4e-03 |
| posterior fossa group A ependymoma | 1.100 | 7.1e-05 |
| subependymal giant cell astrocytoma | 2.153 | 4.3e-03 |
MAGGGSDLSTRGLNGGVSQVANEMNHLPAHSQSLQRLFTEDQDVDEGLVYDTVFKHFKRHKLEISNAIKK 1 - 70 TFPFLEGLRDRELITNKMFEDSEDSCRNLVPVQRVVYNVLSELEKTFNLSVLEALFSEVNMQEYPDLIHI 71 - 140 YKSFKNAIQDKLSFQESDRKEREERPDIKLSLKQGEVPESPEARKESDQACGKMDTVDIANNSTLGKPKR 141 - 210 KRRKKKGHGWSRMGTRTQKNNQQNDNSKADGQLVSSEKKANMNLKDLSKIRGRKRGKPGTHFTQSDRAPQ 211 - 280 KRVRSRASRKHKDETVDFQAPLLPVTCGGVKGILHKEKLEQGTLAKCIQTEDGKWFTPMEFEIKGGYARS 281 - 350 KNWRLSVRCGGWPLRRLMEEGSLPNPPRIYYRNKKRILKSQNNSSVDPCMRNLDECEVCRDGGELFCCDT 351 - 420 CSRVFHEDCHIPPVESEKTPWNCIFCRMKESPGSQQCCQESEVLERQMCPEEQLKCEFLLLKVYCCSESS 421 - 490 FFAKIPYYYYIREACQGLKEPMWLDKIKKRLNEHGYPQVEGFVQDMRLIFQNHRASYKYKDFGQMGLRLE 491 - 560 AEFEKDFKEVFAIQETNGNS 561 - 580 //
